10x Genomics Inc (TXG)
24.08
+0.12
(+0.52%)
USD |
NASDAQ |
May 22, 16:00
24.08
0.00 (0.00%)
After-Hours: 20:00
10x Genomics SG&A Expense (Quarterly): 85.77M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 85.77M |
December 31, 2023 | 86.12M |
September 30, 2023 | 82.42M |
June 30, 2023 | 91.51M |
March 31, 2023 | 83.28M |
December 31, 2022 | 78.89M |
September 30, 2022 | 73.40M |
June 30, 2022 | 79.34M |
March 31, 2022 | 66.68M |
December 31, 2021 | 69.88M |
September 30, 2021 | 62.08M |
June 30, 2021 | 68.70M |
Date | Value |
---|---|
March 31, 2021 | 56.90M |
December 31, 2020 | 55.97M |
September 30, 2020 | 51.55M |
June 30, 2020 | 44.42M |
March 31, 2020 | 50.39M |
December 31, 2019 | 38.76M |
September 30, 2019 | 32.61M |
June 30, 2019 | 32.57M |
March 31, 2019 | 26.89M |
December 31, 2018 | 26.91M |
September 30, 2018 | 19.11M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
32.57M
Minimum
Jun 2019
91.51M
Maximum
Jun 2023
64.56M
Average
67.69M
Median
SG&A Expense (Quarterly) Benchmarks
Teladoc Health Inc | 349.39M |
American Shared Hospital Services | 1.879M |
Novo Integrated Sciences Inc | 2.864M |
Astrana Health Inc | 38.72M |
Cryo-Cell International Inc | 4.340M |